Authors
Latest:
Pandemic-Proof Clinical Study Start-UpThe fear of exposure to SARS-CoV-2 in healthcare settings has deterred people from seeking care for non-COVID-19 diseases. One solution to patient care and biomedical research disruptions is implementing remote solutions for conducting research and collecting samples.
Latest:
How Sponsors Can Use Health Decision Science to Improve Clinical Trial Recruitment and RetentionExamining the behaviors of clinical trial stakeholders to better understand challenges in patient participation.
Latest:
Targeting Patient PopulationKeys to ensuring your clinical trials better reflect your target population.
Latest:
Best Practices for Clinical Trial Technology IntegrationData is the heart of clinical trials, so life sciences firms need to integrate their technology to keep data sources and trial portfolios up-to-date and secure.
Latest:
Fostering Patient-Centricity & DEI : Leveraging Patient Insurance? You’re Missing Out.Webinar Date/Time: Wed, Sep 20, 2023 10:00 AM EDT
Latest:
Delivering Operational Excellence in a Complex Environment of CAR-Directed Cell TherapiesOvercoming saturation in the cell therapy landscape.
Latest:
Enabling Digital Transformation: Managing External Clinical Data Sources to Advance Drug DevelopmentWith an increasing amount of diverse data that must now be collected and analyzed, the industry is faced with increasingly complex studies that present new challenges in data management.
Latest:
Where Do We Go From Here?Lessons from six months of conducting clinical trials during the COVID-19 pandemic
Latest:
Transforming Prospective Study Data Acquisition & DeliveryLearn how your team can use EHR-to-EDC technology to reduce data monitoring costs, speed up data cleaning timelines, and hit study milestones faster.
Latest:
Optimizing Phase III Oncology Trial Recruitment with Data-Driven InsightsA pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
Latest:
Is There a Positive Return on Investment on a Virtual Site?Anticipating the need for both virtual and traditional sites during the planning process can provide high ROI for sponsors.
Latest:
NLP Analyzes the Past to Inform the Future of Clinical Trial DesignNatural language processing can help simplify protocols of the past, as evidenced by a recent Novartis initiative.
Latest:
DCT Risk/Benefit Profile: A Focus on AdherenceAssessing the benefits of digital adherence monitoring for sites and patients.
Latest:
Fast Tracking Study Start-Up from Site Selection to First-Patient EnrollmentWith a major wave of post-COVID trial starts on the horizon, the industry’s need to accelerate clinical research through study start-up is intensifying.
Latest:
Decoding IDMP: Standardizing Global Medicinal Product Documentation for Enhanced Patient Safety, Regulatory Efficiency in the Pharmaceutical IndustryBy promoting the use of a standardized terminology and coding system, IDMP eliminates inconsistencies in regulatory processes.
Latest:
You Are Forgetting the Patient, but You’re Not AloneVincent Keunen, founder and CEO of Andaman7 shares his thoughts on how industry can achieve true patient centricity through emerging platforms and digital tools.
Latest:
Towards a Global Implementation of eConsent in Clinical TrialsAll stakeholders must play part in increasing implementation.
Latest:
Assessing Sponsor and CRO AwarenessImproving receptivity and response to the evolving nature of clinical trial patient oversight.
Latest:
Trials During the Pandemic: A CRO's PerspectiveFindings from an OCT Clinical survey of researchers from 61 sites in Russia to gain the perspective of an investigator regarding clinical trials during the COVID-19 pandemic.
Latest:
Improving Drug Development for Rare Patients Post-COVIDNon-profit biotech organization Cure Rare Disease utilizes collaboration amidst COVID-19 pandemic to catalyze speed of therapeutic research.
Latest:
The Future of Precision Medicine: How Biomarkers Have Influenced Clinical Trial Designs and OutcomesPlanning a clinical trial for precision medicine is markedly more challenging than more conventional treatments, as it must consider patients' variability in genes. Join our webinar to learn how to design a successful precision medicine trial. Live: Wednesday, Oct. 14, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST On demand available after airing until Oct. 14, 2021.
Latest:
Enhancing Patient Experience in Clinical Trials: Six Key Insights from Global Patient SurveysAn overview of key trends in communication, logistical preferences, and demographic influences that shape patient engagement and retention in clinical trials.
Latest:
Rebadging Gains Momentum Amidst COVIDCapacity management and stability offer value for clients, their employees and FSP vendors.
Latest:
Aligning Medical Monitoring and Data ScienceCOVID-19 creates unique challenges for medical monitors.
Latest:
The State of Data FAIRification in Clinical ResearchStudy shows more support is needed for clinical teams to ‘FAIRify’ their data.
Latest:
The Missing Link in Clinical Trial RecruitmentHelping physicians and patients discuss local trials at the point of care.
Latest:
4 Tactics to Encourage Your CRAs and Sites to Adopt Remote Site MonitoringExploring effective strategies for sponsors and CROs to ensure both their CRAs and sites are supported for high levels of site acceptance and streamlined remote monitoring.
Latest:
Initial Design Considerations for Immuno-Oncology TrialsPerspectives and insights regarding regulatory considerations when planning and conducting immunotherapy studies.
Latest:
Managing Clinical Trial AgreementsHow Clinical Research Malaysia sped up CTA turnaround using a web-based system.
